Lundberg agrees: “It would be very interesting to test treatment with IL-6 antibodies in patients with polymyositis, and probably also dermatomyositis.” ...
Idiopathic inflammatory myopathies (IIMs) are associated with autoantibodies against nuclear and cytoplasmic antigens. Myositis-specific autoantibodies (MSAs) are specific to patients with IIMs.